These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10588985)

  • 21. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
    Gross G; Thompson PJ; Chervinsky P; Vanden Burgt J
    Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
    Vanden Burgt JA; Busse WW; Martin RJ; Szefler SJ; Donnell D
    J Allergy Clin Immunol; 2000 Dec; 106(6):1209-26. PubMed ID: 11112914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
    Juniper EF; Buist AS
    Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers.
    Schroeter JD; Sheth P; Hickey AJ; Asgharian B; Price OT; Holt JT; Conti DS; Saluja B
    AAPS PharmSciTech; 2018 Jul; 19(5):2335-2345. PubMed ID: 29858973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
    Busse WW; Brazinsky S; Jacobson K; Stricker W; Schmitt K; Vanden Burgt J; Donnell D; Hannon S; Colice GL
    J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlorofluorocarbon-free inhalation devices in asthma: are there clinical implications?
    Ruffin RE; Southcott AM
    BioDrugs; 1998 Aug; 10(2):91-6. PubMed ID: 18020587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical study.
    Price D; Haughney J; Duerden M; Nicholls C; Moseley C
    Pharmacoeconomics; 2002; 20(10):653-64. PubMed ID: 12162754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD; Walters EG
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
    Wolthers OD
    Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
    Fowler SJ; Currie GP; Lipworth BJ
    J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory Tract Deposition of HFA-Beclomethasone and HFA-Fluticasone in Asthmatic Patients.
    Leach CL; Kuehl PJ; Chand R; McDonald JD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):127-33. PubMed ID: 26061801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
    Szefler SJ; Warner J; Staab D; Wahn U; Le Bourgeois M; van Essen-Zandvliet EE; Arora S; Pedersen S;
    J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children.
    Agertoft L; Laulund LW; Harrison LI; Pedersen S
    Pediatr Pulmonol; 2003 Mar; 35(3):192-9. PubMed ID: 12567387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
    Gillissen A; Richter A; Oster H; Criée CP
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers.
    Gabrio BJ; Stein SW; Velasquez DJ
    Int J Pharm; 1999 Sep; 186(1):3-12. PubMed ID: 10469919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography.
    Goldin JG; Tashkin DP; Kleerup EC; Greaser LE; Haywood UM; Sayre JW; Simmons MD; Suttorp M; Colice GL; Vanden Burgt JA; Aberle DR
    J Allergy Clin Immunol; 1999 Dec; 104(6):S258-67. PubMed ID: 10588987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic differences between chlorofluorocarbon and chlorofluorocarbon-free metered dose inhalers of beclomethasone dipropionate in adult asthmatics.
    Harrison LI; Soria I; Cline AC; Ekholm BP
    J Pharm Pharmacol; 1999 Nov; 51(11):1235-40. PubMed ID: 10632080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
    Dahl R; Ringdal N; Ward SM; Stampone P; Donnell D
    Br J Clin Pract; 1997; 51(1):11-5. PubMed ID: 9158265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability of Beclometasone From Two HFA-BDP Formulations With a Spacer.
    Said AS; AbuRuz S; Chrystyn H
    Respir Care; 2019 Oct; 64(10):1222-1230. PubMed ID: 31138731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.